- Home
- / Estrella Immunopharma
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Estrella Immunopharma financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.9
2024-10-29
Market Capitalization
$32.4 M
2024-10-29
CreditSafe Score
?
Score changed on Jun 14, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2024 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| General and administrative expense | 3.2M | 1.6M | |||
| Operating expense total | 34.8M | 31.9M | |||
| EBIT | (249.1K) | (1.6M) | (7.3M) | (4.4M) | |
| Interest income | 1.4K | 654.1K | |||
| Interest expense | 2.7K | ||||
| Pre tax profit | (247.7K) | (915.5K) | (7.3M) | (4.4M) | (13.1M) |
| Income tax expense | 80.6K | 1.6K | 63.0 | 838.0 | |
| Net Income | (247.7K) | (996.1K) | (7.3M) | (4.4M) | |
| EPS | (0.3) | (0.1) | (0.3) |